Age-related macular degeneration (AMD), classified into dry and wet types, poses a significant threat to the vision of the ...

Older people with diabetes who do not keep blood sugar levels low are three times more likely to develop eye disease compared ...

In this video from Clinical Trials at the Summit, Carl D. Regillo, MD, FACS, discusses the use of tyrosine kinase inhibitors for wet age-related macular degeneration and diabetic retinopathy with ...

Whether you’re a latte lover, a mocha monster or an espresso elitist — people have strong preferences when it comes to coffee ...

Newer techniques using nanoparticles are less invasive, but some need bright visible light, which can harm any remaining ...

Alcon has inked a deal to acquire LumiThera and its light-based therapy for dry age-related macular degeneration, which obtained a groundbreaking FDA clearance late last year. | LumiThera's approach ...

Age-related macular degeneration (AMD) is a leading cause of vision loss in older adults. Current treatments mainly address advanced AMD, while early or intermediate stages rely only on micronutrient ...

PST-611-CT1 is a first-in-human single ascending dose study that aims to establish, in six to a maximum of 12 dry AMD/GA patients, the safety profile of the drug and validate the maximal tolerated ...

A new study links urinary metabolites from organophosphorus pesticides to increased age-related macular degeneration risk.

A new study examining the dietary habits of more than half a million people has found that instant coffee consumption may ...

A new study identifies how the molecule, called ApoM, can clear harmful cholesterol deposits linked to macular degeneration ...

D Molecular Therapeutics (NASDAQ:FDMT) announces a 25% workforce reduction to streamline operations and fund 4D-150's ...